Coronavirus: New inhaled vaccine gets emergency use approval in China

It will be used as a booster



By Reuters

Published: Sun 4 Sep 2022, 12:51 PM

CanSino Biologics Inc's inhaled version of its adenovirus-vectored Covid-19 vaccine has been approved by China's medical products regulator for emergency use as a booster, the company said in a filing on Sunday.

ALSO READ:


More news from coronavirus